NCT06966947 is a clinical trial of Risk Early Warning Management in Hip Fractures (ICD-10 72.01-72.2), sponsored by People's Hospital Affiliated to Hubei University of Medicine.

Who is sponsoring NCT06966947?

NCT06966947 is sponsored by People's Hospital Affiliated to Hubei University of Medicine.

What drugs are being tested in NCT06966947?

Interventions in NCT06966947: Risk Early Warning Management, Standard Perioperative Care.

What condition does NCT06966947 study?

NCT06966947 studies Hip Fractures (ICD-10 72.01-72.2).

Is NCT06966947 still recruiting?

NCT06966947 is currently completed. Last updated 13 May 2025.

Last reviewed 2025-05-13 · How we verify

NCT06966947

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Risk Early Warning Management for Postoperative Hip Fracture Rehabilitation and Delirium Prevention in Elderly Patients

Completed Last updated 13 May 2025

What this trial tests

trial testing Risk Early Warning Management in Hip Fractures (ICD-10 72.01-72.2) in 284 participants. Completed in 31 December 2023.

Timeline

1 January 2023

Primary endpoint
31 December 2023

31 December 2023

Quick facts

Lead sponsor	People's Hospital Affiliated to Hubei University of Medicine
Status	Completed
Study type	OBSERVATIONAL
Enrollment	284
Start date	1 January 2023
Primary completion	31 December 2023
Estimated completion	31 December 2023
Sites	1 location across China

Drugs / interventions tested

Risk Early Warning Management
Standard Perioperative Care

Conditions studied

Hip Fractures (ICD-10 72.01-72.2) — all drugs for Hip Fractures (ICD-10 72.01-72.2) →

Sponsor

People's Hospital Affiliated to Hubei University of Medicine

Who can join

18 and older, any sex, with Hip Fractures (ICD-10 72.01-72.2). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This clinical study aims to evaluate the effectiveness of a perioperative risk early warning management strategy in patients undergoing surgical treatment for hip fractures. Hip fractures are common in elderly individuals and are associated with a high risk of postoperative complications. Traditional perioperative care may not sufficiently identify and respond to early signs of clinical deterioration. In this study, patients with hip fractures admitted to the orthopedic department of a single hospital from January 2023 to December 2023 were divided into two groups based on their admission time. Patients admitted between June and December 2023 received the early warning risk management intervention (experimental group), while those admitted between January and May 2023 received routine perioperative care (control group). The early warning management system involved a scoring-based approach using vital signs such as heart rate, respiratory rate, blood pressure, body temperature, and consciousness level to classify patients' risk levels. Nursing staff responded with graded interventions, including enhanced monitoring and rapid physician notification for higher-risk patients. The study retrospectively enrolled 284 patients in total, with 142 in each group. The primary outcomes include changes in coagulation function, self-care ability (measured by the Exercise of Self-care Agency Scale, ESCA), and hip joint functional recovery (measured by the Hospital for Special Surgery, HSS, score). Secondary outcomes include patient satisfaction and incidence of postoperative complications. The central hypothesis is that perioperative risk early warning management will improve patient safety, enhance self-care capacity, reduce complications, and promote better recovery outcomes compared to routine care.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Hip Fractures (ICD-10 72.01-72.2)

Currently open trials in the same condition.

NCT06678529 — Effect of Transcranial Direct Current Stimulation on Postoperative Delirium in Elderly Patients · NA · recruiting
NCT07189260 — Pre- and Postoperative Chest Therapy With Positive Expiratory Pressure (PEP) to Prevent Hospital-acquired Pneumonia · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06966947 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by People's Hospital Affiliated to Hubei University of Medicine
Last refreshed: 13 May 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06966947.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing